Skip to Content Facebook Feature Image

Parnell Expands PropofolVet Multidose Offering with New 50 mL Presentation

Business

Parnell Expands PropofolVet Multidose Offering with New 50 mL Presentation
Business

Business

Parnell Expands PropofolVet Multidose Offering with New 50 mL Presentation

2026-07-28 21:12 Last Updated At:21:30

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Jul 28, 2026--

Parnell today announced the availability of a new 50 mL presentation of PropofolVet Multidose (propofol injectable emulsion), providing veterinary professionals with an additional option to support anesthesia protocols while helping optimize inventory management and reduce waste. The new presentation complements the existing 20 mL offering, extending the reach of Parnell's first generic propofol injectable emulsion for dogs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260728872796/en/

PropofolVet Multidose is indicated for use in dogs for induction of anesthesia, maintenance of general anesthesia by intermittent bolus injections for short procedures, and induction of general anesthesia when maintenance is provided by inhalant anesthetics. The new 50 mL presentation is designed to help practices better align product selection with patient volume and workflow needs. Like the existing presentation, the product offers a 28-day in-use shelf life with no refrigeration required, helping veterinary teams maximize product utilization while simplifying storage and handling requirements.

"Veterinary practices continue to look for ways to improve operational efficiency while delivering excellent patient care," said Pablo Lamberto, DVM, U.S. General Manager at Parnell. "By expanding PropofolVet Multidose with a 50 mL presentation, we are giving clinics another tool to support their anesthesia protocols and manage inventory more effectively."

The 50 mL presentation of PropofolVet Multidose further strengthens Parnell's growing anesthesia and sedation portfolio, which includes Dexmedetomidine Hydrochloride Injection, CONTRASED™ (atipamezole hydrochloride), Isoflurane Inhalation Anesthetic, and Sevoflurane Inhalation Anesthetic.

Key Features

For more information, visit www.parnell.com or contact your local distributor representative.

Supporting the Whole Team

Parnell's commitment to veterinary teams extends beyond the product. The Foundations of Anesthesia & Sedation Certificate Program, an online course offering 10 RACE-approved CE hours, is designed to build staff competency and confidence in anesthesia protocols. For practices investing in both clinical excellence and team development, the program complements the portfolio as part of a broader support ecosystem. Learn more at parnell.com/education.

About Parnell

Parnell is a veterinary pharmaceutical company focused on developing, manufacturing, and commercializing animal health solutions across anesthesia and beyond. With a strong commitment to quality and customer partnerships, Parnell manufactures and markets products for companion and production animals in 10 countries. Learn more at www.parnell.com.

©2026 Parnell Technologies Pty LTD. CONTRASED is a trademark of Parnell Technologies Pty LTD. MKT-26-146 PC US

Parnell PropofolVet Multidose 50 mL

Parnell PropofolVet Multidose 50 mL

BUFFALO, N.Y. (AP) — The man on trial in the stabbing of Salman Rushdie chose Tuesday not to testify or call any witnesses in the federal terrorism case, which is expected to head to the jury as soon as Wednesday.

Hadi Matar's lawyer told the court that the 28-year-old — who already has been convicted of state-level attempted murder charges — wouldn't take the stand at his trial on charges that include engaging in an act of transnational terrorism.

“At this time, the defense rests,” attorney Nathaniel Barone said. Matar has pleaded not guilty.

Prosecutors also rested their case Tuesday, and closing arguments are expected Wednesday morning. Rushdie, the prize-winning author of novels including “Midnight’s Children” and the controversial “The Satanic Verses,” testified last week about the 2022 attack that nearly killed him and left him blind in one eye.

Rushdie was about to give a talk — about writers' safety, no less — when his attacker climbed on stage behind him and stabbed him 15 times in front of a stunned audience at the Chautauqua Institution, an arts and intellectual retreat.

Spectators and another speaker, Henry Reese, scrambled to aid Rushdie and restrain the assailant, who was arrested by law enforcement officers assigned to the event. He initially gave authorities a fake driver's license, but Matar soon disclosed his real name to a state trooper, according the trooper's testimony and body camera video.

Prosecutors contend that Matar was acting upon a former Iranian leader's 1989 call for Rushdie's death because of “The Satanic Verses,” which ignited protests across the Muslim world. Some believers considered it blasphemous because of a dream sequence featuring Islam's Prophet Muhammad.

Rushdie, who was born in India into a Muslim family and is now a U.S. citizen, went into hiding for years. He gradually emerged after Iran's government distanced itself in 1998 from the late Ayatollah Ruhollah Khomeini 's fatwa, or religious order, about the writer.

Prosecutors say Matar, a U.S.-born American-Lebanese citizen, acted out of loyalty to Iran and to the Lebanon-based Hezbollah militant group. The late Hezbollah leader Hassan Nasrallah said in 2006 that if someone had carried out the fatwa, European newspapers wouldn't have dared publish a caricature of Muhammad that was causing an uproar in Muslim communities.

Iran’s government denied involvement in the 2022 stabbing, though its Foreign Ministry’s then-spokesperson suggested Rushdie courted trouble by insulting Islam. Nasrallah did not comment on the attack.

Matar started researching Rushdie's whereabouts in 2020, eventually writing in private notes that “we need to kill him ASAP” and “become a warrior and just get it over with,” prosecutors have said.

Matar didn't testify at his 2025 state court trial, either. his lawyer has said federal prosecutors are making implications but don't have proof about the man’s intentions.

“There’s no facts. There’s no hard evidence,” Barone said in an interview outside the courthouse last week. “There could be a number of reasonable, plausible explanations as to what he was thinking.”

Barone unsuccessfully argued Tuesday that prosecutors hadn't presented enough evidence for the trial to continue. A judge declined Barone's request to dismiss the case.

Matar is currently serving a 25-year state prison sentence. If convicted in the federal case, he faces a potential life sentence.

Peltz reported from New York.

In this courtroom sketch, Salman Rushdie, left, testifies in federal court during the terrorism trial for Hadi Matar, Rushdie's alleged attacker, shown second from bottom left, Thursday, July 23, 2026, in Buffalo, N.Y. (Alexandra Newbould via AP)

In this courtroom sketch, Salman Rushdie, left, testifies in federal court during the terrorism trial for Hadi Matar, Rushdie's alleged attacker, shown second from bottom left, Thursday, July 23, 2026, in Buffalo, N.Y. (Alexandra Newbould via AP)

In this courtroom sketch, Salman Rushdie, left, testifies in federal court during the terrorism trial for Hadi Matar, Rushdie's alleged attacker, Thursday, July 23, 2026, in Buffalo, N.Y. (Alexandra Newbould via AP)

In this courtroom sketch, Salman Rushdie, left, testifies in federal court during the terrorism trial for Hadi Matar, Rushdie's alleged attacker, Thursday, July 23, 2026, in Buffalo, N.Y. (Alexandra Newbould via AP)

FILE - Hadi Matar walks in to the Chautauqua County court in Mayville, N.Y., May, 16, 2025. (AP Photo/Adrian Kraus, File)

FILE - Hadi Matar walks in to the Chautauqua County court in Mayville, N.Y., May, 16, 2025. (AP Photo/Adrian Kraus, File)

FILE - Novelist Salman Rushdie attends the premiere of the documentary film "Knife: The Attempted Murder of Salman Rushdie" during the Sundance Film Festival on Jan. 25, 2026, at The Ray in Park City, Utah. (AP Photo/Chris Pizzello, File)

FILE - Novelist Salman Rushdie attends the premiere of the documentary film "Knife: The Attempted Murder of Salman Rushdie" during the Sundance Film Festival on Jan. 25, 2026, at The Ray in Park City, Utah. (AP Photo/Chris Pizzello, File)

In this courtroom sketch, Hadi Matar, center, sits in federal court during his terrorism trial for his alleged attack on Salman Rushdie, Wednesday, July 22, 2026, in Buffalo, N.Y. (Alexandra Newbould via AP)

In this courtroom sketch, Hadi Matar, center, sits in federal court during his terrorism trial for his alleged attack on Salman Rushdie, Wednesday, July 22, 2026, in Buffalo, N.Y. (Alexandra Newbould via AP)

Recommended Articles